2254082-79-4

2254082-79-4 structure
2254082-79-4 structure
  • Name: Isecarosmab
  • Chemical Name: Isecarosmab
  • CAS Number: 2254082-79-4
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Research Areas Inflammation/Immunology
  • Create Date: 2023-04-02 18:31:56
  • Modify Date: 2024-04-09 18:32:08
  • Isecarosmab (M-6495) is an anti-ADAMTS monoclonal antibody (mAb) with a KD value of 3.65 pM. Isecarosmab has chondroprotective and anti-inflammatory activities. Isecarosmab can bind albumin to extend plasma half-life[1][2][3].

Name Isecarosmab
Description Isecarosmab (M-6495) is an anti-ADAMTS monoclonal antibody (mAb) with a KD value of 3.65 pM. Isecarosmab has chondroprotective and anti-inflammatory activities. Isecarosmab can bind albumin to extend plasma half-life[1][2][3].
Related Catalog
In Vitro Isecarosmab 结合 ADAMTS-5,但不结合 ADAMTS-1、ADAMTS-4 和 ADAMTS-15[1]。 Isecarosmab (1-100 nM,5 天) 在受到促炎刺激的牛和 OA 人软骨外植体中降低 huARGS、exAGNxI 和 GAG 水平[1]。 Isecarosmab (24-72 h) 阻断 ADAMTS-5 介导的 DCS TLR2 激活[2]。
In Vivo Isecarosmab (0.1-10 mg/kg,皮下注射,每三天一次) 减轻内侧半月板 (DMM) 切除小鼠的内侧软骨退化[1]。
References

[1]. Siebuhr AS, et al. The Anti-ADAMTS-5 Nanobody® M6495 Protects Cartilage Degradation Ex Vivo. Int J Mol Sci. 2020 Aug 20;21(17):5992.  

[2]. Sharma N, et al. Inflammation and joint destruction may be linked to the generation of cartilage metabolites of ADAMTS-5 through activation of toll-like receptors. Osteoarthritis Cartilage. 2020 May;28(5):658-668.  

[3]. C. Brenneis. Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495). 2018. 26 (1), S299-S300.

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.